EPC 2025 COPD GSK Podcast Evaluation

Course Title for Certificate

Name

First NameLast Name

Email

example@example.com

What best describes your title?

How many years have you been in practice?

1. What proportion of patients who experience a severe COPD exacerbation are re-hospitalized within 30 days?

2. Which of the following should be the initial pharmacologic treatment plan for a patient diagnosed with COPD who is in GOLD group E?

3. In the Phase 3 MATINEE trial, treatment with Mepolizumab was associated with reductions in COPD exacerbations of:

How many patients do you currently see each month regarding chronic obstructive pulmonary disease (COPD)?

Learning Objectives

Rows	Poor	Fair	Good	Very Good	Excellent
Describe updates to the latest iteration of GOLD guidelines that outline optimal diagnostic and treatment procedures for individuals with type 2 eosinophilic
Assess the efficacy, safety, and mechanisms of action of newly approved and emerging pharmacotherapy for patients with type 2 eosinophilic COPD
Select the most appropriate therapeutic strategy for patients with type 2 eosinophilic COPD on the basis of relevant clinical factors

Please provide us with feedback regarding your experience at the activity:

Rows	Poor	Fair	Good	Very Good	Excellent
Overall
Content
Usefulness

Do you feel this activity was fair, balanced, and free of commercial bias?

If no, please explain:

This educational activity will result in a change in my role as a healthcare team member.

Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

What factors beyond clinical care that effect the health of your patients does your team experience?

Attestation:

AcademicCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Date

Credits